| Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study MJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ... The Lancet 387 (10019), 679-690, 2016 | 1872 | 2016 |
| NASH in lean individuals R Younes, E Bugianesi Seminars in liver disease 39 (01), 086-095, 2019 | 229 | 2019 |
| Surgical excision margins in primary cutaneous melanoma: a meta-analysis and Bayesian probability evaluation K Wheatley, JS Wilson, P Gaunt, JR Marsden Cancer treatment reviews 42, 73-81, 2016 | 87 | 2016 |
| Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial MJ Armstrong, D Barton, P Gaunt, D Hull, K Guo, D Stocken, SCL Gough, ... BMJ open 3 (11), e003995, 2013 | 65 | 2013 |
| UKMCC-01: A phase II study of pazopanib (PAZ) in metastatic Merkel cell carcinoma. PD Nathan, P Gaunt, K Wheatley, SJ Bowden, J Savage, G Faust, ... Journal of Clinical Oncology 34 (15_suppl), 9542-9542, 2016 | 29 | 2016 |
| P1. 07-015 STOMP: a UK national cancer research network randomised, double blind, multicentre phase II trial of olaparib as maintenance therapy in SCLC: topic: drug treatment … P Woll, P Gaunt, N Steele, S Ahmed, C Mulatero, R Shah, S Danson, ... Journal of Thoracic Oncology 12 (1), S704-S705, 2017 | 26 | 2017 |
| Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: results from a British Thoracic Oncology … D Ferry, L Billingham, H Jarrett, D Dunlop, PJ Woll, M Nicolson, R Shah, ... European Journal of Cancer 83, 302-312, 2017 | 25 | 2017 |
| G01: Liraglutide is effective in the histological clearance of non-alcoholic steatohepatitis in a multicentre, doubleblinded, randomised, placebo-controlled phase II trial MJ Armstrong, P Gaunt, GP Aithal, R Parker, D Barton, D Hull, K Guo, ... Journal of Hepatology, S187, 2015 | 24 | 2015 |
| Early phase clinical trials extension to guidelines for the content of statistical analysis plans V Homer, C Yap, S Bond, J Holmes, D Stocken, K Walker, EJ Robinson, ... bmj 376, 2022 | 22 | 2022 |
| The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma L Forker, P Gaunt, S Sioletic, P Shenjere, R Potter, D Roberts, J Irlam, ... British journal of cancer 118 (5), 698-704, 2018 | 22 | 2018 |
| Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): a randomised, double-blind, placebo-controlled phase II trial P Woll, P Gaunt, S Danson, N Steele, S Ahmed, C Mulatero, R Shah, ... Lung Cancer 171, 26-33, 2022 | 17 | 2022 |
| Clinicians' views of patient-initiated follow-up in head and neck cancer: a qualitative study to inform the PETNECK2 trial A Lorenc, M Wells, T Fulton-Lieuw, P Nankivell, H Mehanna, M Jepson, ... Clinical Oncology 34 (4), 230-240, 2022 | 17 | 2022 |
| Feasibility of dose-escalated hypofractionated chemoradiation in human papilloma virus-negative or smoking-associated oropharyngeal cancer S Meade, P Gaunt, A Hartley, M Robinson, V Harrop, J Cashmore, ... Clinical Oncology 30 (6), 366-374, 2018 | 17 | 2018 |
| team Lt, Abouda G, Aldersley MA, Stocken D, Gough SC, Tomlinson JW, Brown RM, Hubscher SG, Newsome PN. Liraglutide safety and efficacy in patients with non-alcoholic … MJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ... Lancet 387 (10019), 679-90, 2016 | 16 | 2016 |
| Vortex trial: a randomized controlled multicenter phase 3 trial of volume of postoperative radiation therapy given to adult patients with extremity soft tissue sarcoma (STS) MH Robinson, P Gaunt, R Grimer, B Seddon, J Wylie, A Davis, D Hughes, ... International Journal of Radiation Oncology, Biology, Physics 96 (2), S1, 2016 | 15 | 2016 |
| Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using … ZU Hasan, I Ahmed, RN Matin, V Homer, JT Lear, F Ismail, T Whitmarsh, ... British Journal of Dermatology 187 (3), 324-337, 2022 | 14 | 2022 |
| Phase III randomised controlled trial (RCT) comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer (CompARE). HM Mehanna, M Sen, JD Chester, P Sanghera, V Paleri, P Gaunt, ... Journal of Clinical Oncology 35 (15_suppl), TPS6091-TPS6091, 2017 | 12 | 2017 |
| Identifying patients with nonalcoholic steatohepatitis that are nonresponders to therapy MJ Armstrong, P Gaunt, PN Newsome Hepatology 64 (6), 2265-2266, 2016 | 6 | 2016 |
| S86 Quality of life in advanced non-small cell lung cancer, effects of cisplatin dose and carboplatin in combination with gemcitabine: results from BTOG2, a British Thoracic … LJ Billingham, P Gaunt, HW Jarrett, D Dunlop, J Thompson, KJ O'byrne, ... Thorax 66 (Suppl 4), A41-A41, 2011 | 5 | 2011 |
| Developing a standardized actinic keratosis assessment protocol RN Matin, P Gaunt, DL McCartney, F Ismail, SJ Bowden, JM McGregor, ... British Journal of Dermatology 169 (Suppl. 1), 101, 2013 | 4 | 2013 |
